Use of tamoxifen in asymptomatic patients with recurrent small-volume ovarian cancer.
Gynecologic Oncology(2004)
Abstract
Objectives. Tamoxifen, a well-tolerated oral hormonal agent with biological activity in ovarian cancer, is a potentially attractive option in asymptomatic patients with recurrent disease. Unfortunately, the clinical utility of the drug in this specific setting has not been well documented.
MoreTranslated text
Key words
Ovarian cancer,Tamoxifen,Chemotherapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined